FAQs
Case
Status
Print
this pageSelected Medical Journal Web Links
This page lists recent medical journal articles about beryllium, asbestos, and asbestos–related diseases such as asbestosis, lung cancer, and mesothelioma. Articles are listed within chronological order within each category. Also see general medical links.
Some of these links refer to the full text of articles; others refer to abstracts only. Many articles are available in full text through PubMed, the National Library of Medicine’s search engine.
Asbestosis
Nonmalignant
asbestos–related diseases in Brazilian asbestos–cement workers.
Algranti E, Mendonca EM, DeCapitani EM, Freitas JB, Silva HC, Bussacos MA.
Am J Ind Med. 2001 Sep;40(3):240–54.
High–resolution
computed tomography classification of lung fibrosis for patients with asbestos–related
disease.
Huuskonen O, Kivisaari L, Zitting A, Taskinen K, Tossavainen A, Vehmas T
Scand J Work Environ Health. 2001 Apr;27(2):106–12.
Beryllium
High
Beryllium–stimulated TNF–alpha Is Associated with the –308 TNF–alpha Promoter
Polymorphism and with Clinical Severity in Chronic Beryllium Disease
Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, Dubois R, Daniloff
E, Rose CS, Newman LS.
Am J Respir Crit Care Med. 2001 Oct 1;164(7):1192–1199.
Beryllium
sensitivity is linked to HLA–DP genotype.
Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL.
Toxicology. 2001 Aug 13;165(1):27–38.
Chronic
beryllium disease: T cell recognition of a metal presented by HLA–DP.
Fontenot AP, Newman LS, Kotzin BL.
Clin Immunol. 2001 Jul;100(1):4–14.
Chronic
beryllium disease: a hypersensitivity disorder.
Rossman MD.
Appl Occup Environ Hyg. 2001 May;16(5):615–8.
Exposure to Asbestos
Malignant
pleural mesothelioma in bakers and pastry cooks.
Ascoli V, Calisti R, Carnovale–Scalzo C, Nardi F.
Am J Ind Med. 2001 Oct;40(4):371–3.
Asbestos
exposure assessment by mineralogical analysis of bronchoalveolar lavage fluid.
Sartorelli P, Scancarello G, Romeo R, Marciano G, Rottoli P, Arcangeli G, Palmi
S.J Occup Environ Med. 2001 Oct;43(10):872–81.
Lung Cancer
Cancer
mortality among workers exposed to amphibole–free chrysotile asbestos.
Yano E, Wang ZM, Wang XR, Wang MZ, Lan YJ.
Am J Epidemiol. 2001 Sep 15;154(6):538–43.
Frequency
and risk of bronchopulmonary neoplasia related to asbestos.
Badorrey MI, Monso E, Teixido A, Pifarre R, Rosell A, Llatjos M
Med Clin (Barc). 2001 Jun 9;117(1):1–6. Spanish.
Mesothelioma
High–dose
doxorubicin, dexrazoxane, and GM–CSF in malignant mesothelioma: a phase II
study–Cancer and Leukemia Group B 9631.
Kosty MP, Herndon JE, Vogelzang NJ, Kindler HL, Green MR.
Lung Cancer. 2001 Nov;34(2):289–95.
Therapeutic
outcome according to histologic subtype in 121 patients with malignant pleural
mesothelioma.
Ceresoli GL, Locati LdeB, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini
P, Bolognesi A, Villa E.
Lung Cancer. 2001 Nov;34(2):279–87.
Prospective
trial for the treatment of malignant peritoneal mesothelioma.
Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR, Levine EA
Am Surg. 2001 Oct;67(10):999–1003.
A
phase II trial of surgical resection and adjuvant high–dose hemithoracic
radiation for malignant pleural mesothelioma.
Rusch VW, Rosenzweig K, Venkatraman E, Leon L, Raben A, Harrison L, Bains MS,
Downey RJ, Ginsberg RJ.
J Thorac Cardiovasc Surg. 2001 Oct;122(4):788–95.
Combined
regimen of cisplatin, doxorubicin, and alpha–2b interferon in the treatment
of advanced malignant pleural mesothelioma: a Phase II multicenter trial
of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task
Force (FONICAP).
Parra HS, Tixi L, Latteri F, Bretti S, Alloisio M, Gravina A, Lionetto R, Bruzzi
P, Dani C, Rosso R, Cosso M, Balzarini L, Santoro A, Ardizzoni A.
Cancer. 2001 Aug 1;92(3):650–6.